Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

3 clinical studies listed.

Filters:

Diabetic Macular Oedema

Tundra lists 3 Diabetic Macular Oedema clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

COMPLETED

NCT07844343

A Trial to Evaluate the Safety and Usability of the SB15 PFS in Trial Participants With AMD, Macular Oedema Secondary to RVO, or Diabetic Macular Oedema

This is an open label, multicenter, Phase II trial to evaluate the safety and usability of the pre-filled syringe (PFS) of SB15 (Aflibercept biosimilar). Healthcare Professionals (HCPs) followed the Instructions for Use (IFU) to prepare and administer SB15 PFS with intravitreal injection to trial participants with nAMD, Macular Oedema Secondary to RVO, or Diabetic Macular Oedema (DME).

Gender: All

Ages: 19 Years - Any

Updated: 2026-10-15

1 state

Neovascular Age-related Macular Degeneration
Macular Oedema Secondary to RVO
Diabetic Macular Oedema
COMPLETED

NCT07816627

Applied Conversion Equation for Optical Coherence Tomography

The investigator wants to investigate how big the differences are between measurements of the back of the eye taken by different OCT machines. The study is called: Applied Conversion Equation for Optical Coherence Tomography (ACE-OCT) study.

Gender: All

Ages: 18 Years - Any

Updated: 2026-09-14

1 state

Diabetic Macular Oedema
ACTIVE NOT RECRUITING

NCT06908876

A Study to Evaluate the Efficacy and Safety of IBI302 inSubjects With Diabetic Macular Edema(DME)

The study is designed for multi-center,randomized,double-masked,active-contralledstudy to evaluate effective and security of intravitrealinjection of IBI302 in subjects with Diabetic Macular Oedema.

Gender: All

Ages: 18 Years - 80 Years

Updated: 2026-05-27

1 state

Diabetic Macular Oedema